Literature DB >> 1358887

Beta-adrenergic agonists that down-regulate receptor mRNA up-regulate a M(r) 35,000 protein(s) that selectively binds to beta-adrenergic receptor mRNAs.

J D Port1, L Y Huang, C C Malbon.   

Abstract

In an effort to explore the molecular basis for agonist-induced destabilization of beta-adrenergic receptor mRNA, we investigated the nature of RNA-binding proteins both in untreated and agonist-treated DDT1-MF2 smooth muscle cells. Messenger RNAs for the alpha 1b-, beta 1-, and beta 2-adrenergic receptors as well as for beta-globin were transcribed in vitro, incubated with cytosolic fractions, covalently cross-linked by short-wave UV light, and analyzed by SDS-polyacrylamide gel electrophoresis. A prominent M(r) 35,000 radiolabeled protein(s) with the following characteristics was identified: (i) binds selectively to beta 1- and beta 2-adrenergic receptor mRNAs, both of which undergo agonist-induced down-regulation; (ii) does not bind to either alpha 1b-adrenergic receptor mRNA, which does not undergo agonist induced down-regulation, or to beta-globin mRNA; (iii) displays binding to beta 2-adrenergic receptor mRNA that is selectively competed by poly(U) RNA, but not poly(A), -(C), or -(G) RNA; and (iv) displays binding to receptor mRNA that can be competed by RNA harboring destabilizer sequences that are AU-rich and AUUUA pentamer-rich. The abundance of the M(r) 35,000 RNA-binding protein selective for beta-adrenergic receptor message, a factor we term beta ARB protein, varies inversely with the level of receptor mRNA, being induced by agonists that down-regulate receptor mRNA.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1358887

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  25 in total

1.  Changes in intracellular localization of calpastatin during calpain activation.

Authors:  R De Tullio; M Passalacqua; M Averna; F Salamino; E Melloni; S Pontremoli
Journal:  Biochem J       Date:  1999-10-15       Impact factor: 3.857

2.  The role of 3'-untranslated region (3'-UTR) mediated mRNA stability in cardiovascular pathophysiology.

Authors:  C M Misquitta; V R Iyer; E S Werstiuk; A K Grover
Journal:  Mol Cell Biochem       Date:  2001-08       Impact factor: 3.396

3.  Homologous regulation of the alpha2C-adrenoceptor subtype in human hepatocarcinoma, HepG2.

Authors:  C Cayla; S Schaak; C Roquelaine; C Gales; F Quinchon; H Paris
Journal:  Br J Pharmacol       Date:  1999-01       Impact factor: 8.739

Review 4.  Alterations in adrenergic receptor signaling in heart failure.

Authors:  S Lamba; W T Abraham
Journal:  Heart Fail Rev       Date:  2000-03       Impact factor: 4.214

5.  Regulation of luteinizing hormone receptor mRNA expression by a specific RNA binding protein in the ovary.

Authors:  K M J Menon; Anil K Nair; Lei Wang; Helle Peegel
Journal:  Mol Cell Endocrinol       Date:  2006-10-19       Impact factor: 4.102

6.  Endothelial cytosolic proteins bind to the 3' untranslated region of endothelial nitric oxide synthase mRNA: regulation by tumor necrosis factor alpha.

Authors:  J Alonso; L Sánchez de Miguel; M Montón; S Casado; A López-Farré
Journal:  Mol Cell Biol       Date:  1997-10       Impact factor: 4.272

7.  Identification of nuclear and cytoplasmic proteins that interact specifically with an AU-rich, cis-acting inhibitory sequence in the 3' untranslated region of human papillomavirus type 1 late mRNAs.

Authors:  C Zhao; W Tan; M Sokolowski; S Schwartz
Journal:  J Virol       Date:  1996-06       Impact factor: 5.103

8.  Functional role for the angiotensin II receptor (AT1A) 3'-untranslated region in determining cellular responses to agonist: evidence for recognition by RNA binding proteins.

Authors:  T J Thekkumkara; W G Thomas; T J Motel; K M Baker
Journal:  Biochem J       Date:  1998-01-15       Impact factor: 3.857

Review 9.  Regulatory mechanisms that modulate signalling by G-protein-coupled receptors.

Authors:  S K Böhm; E F Grady; N W Bunnett
Journal:  Biochem J       Date:  1997-02-15       Impact factor: 3.857

10.  Protective effects of a glucocorticoid on downregulation of pulmonary beta 2-adrenergic receptors in vivo.

Authors:  J C Mak; M Nishikawa; H Shirasaki; K Miyayasu; P J Barnes
Journal:  J Clin Invest       Date:  1995-07       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.